ASX:IIQ INOVIQ (IIQ) Stock Price, News & Analysis → This unknown company solves the biggest issue with AI (From Manward Press) (Ad) Free IIQ Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield15.56%Price TargetN/A Stock AnalysisStock Analysis Get INOVIQ alerts: Email Address Ad Weiss RatingsHe cracked the code to crypto…Juan Villaverde has cracked the code to crypto.Click now for the best way into the newest AI projects About INOVIQINOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample. Its cancer diagnostic pipeline includes blood tests in development for ovarian, breast, and other cancers. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was incorporated in 1983 and is headquartered in Notting Hill, Australia.Read More Ad Weiss RatingsHe cracked the code to crypto…Juan Villaverde has cracked the code to crypto.Click now for the best way into the newest AI projects IIQ Stock News HeadlinesAugust 31, 2023 | finance.yahoo.comINOVIQ Full Year 2023 Earnings: AU$0.097 loss per share (vs AU$0.20 loss in FY 2022)August 16, 2023 | finance.yahoo.comIIQ.AX - INOVIQ LtdAugust 14, 2023 | finance.yahoo.comEXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TESTAugust 14, 2023 | finance.yahoo.comINOVIQ (ASX:IIQ) shareholders have earned a 17% CAGR over the last five yearsOctober 28, 2022 | finance.yahoo.comWe're Hopeful That INOVIQ (ASX:IIQ) Will Use Its Cash WiselySee More Headlines Receive IIQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for INOVIQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:IIQ CUSIPN/A CIKN/A Webwww.inoviq.com Phone61 3 9548 7586FaxN/AEmployees15Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,510,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-32.85% Return on Assets-19.14% Debt Debt-to-Equity Ratio3.41 Current Ratio4.94 Quick Ratio9.52 Sales & Book Value Annual Sales$1.58 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.18 per share Price / BookN/AMiscellaneous Outstanding Shares92,020,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta2.20 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Leearne Maree Hinch B.Sc.B.V.M.S., BSc., M.B.A., M.R.C.V.S., Chief Executive OfficerMr. Mark Edwards BAccC.A., CA, CFO & Company SecretaryProf. Gregory Edward Rice BSc (Hons)GradDipMgt, MHA, Ph.D., Chief Scientific OfficerKey CompetitorsANGLEOTCMKTS:ANPCYAustralian Clinical LabsASX:ACLBARD1 Life SciencesASX:BD1BCAL DiagnosticsASX:BDXbioAffinity TechnologiesNASDAQ:BIAFWView All Competitors This page (ASX:IIQ) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon to Transform U.S. Economy? Porter & CompanyThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INOVIQ Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
